Age Related Macular Degeneration

• Macugen Therapy
• Lucentis Therapy
• Avastin Therapy

We are offering Lucentis therapy for the treatment of wet macular degeneration. This is a newly FDA approved drug. It does require dilation of the pupils and is administered as a painless eye injection in the office. A series of treatments is usually required.

Lucentis is a prescription medication for the treatment of patients with wet macular degeneration. As mentioned earlier in on this page wet macular degeneration involves the leaking of blood vessels onto the retina. After receiving FDA approval in June of 2006 Lucentis has become a guiding light source for patients once facing blindness.

Prior to receiving your Lucentis injection your eye will be prepped and cleaned in order to prevent any type of infection. Our retina specialists will then numb your eye to limit any discomfort. Patients do report slight pressure on the eye. Once the injection has passed the pressure will subside.

Lucentis Facts (courtesy of Genentech USA):

    • It is FDA approved for wet ARMD and was developed specifically for use in the eye
    • Efficacy and safety of LUCENTIS was tested in clinical studies of more than 800 people over 2 years
    • In clinical studies, patients treated monthly for up to 2 years saw their vision stabilize or improve. In fact, 9 out of 10 people saw their vision stabilize (which means they lost fewer than 15 letters on the eye chart), and up to 4 out of 10 people saw a 3-line gain on the eye chart (which means they could see an additional 15 letters)